Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anini, Y.
Right arrow Articles by Brubaker, P. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anini, Y.
Right arrow Articles by Brubaker, P. L.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 52:252-259, 2003
© 2003 by the American Diabetes Association, Inc.

Role of Leptin in the Regulation of Glucagon-Like Peptide-1 Secretion

Younes Anini1, and Patricia L. Brubaker1,2

1 Department of Physiology, University of Toronto, Toronto, Ontario, Canada
2 Department of Medicine, University of Toronto, Toronto, Ontario, Canada

Glucagon-like peptide-1 (GLP-1), released from intestinal endocrine L cells, is a potent insulinotropic hormone. GLP-1 secretion is diminished in obese patients. Because obesity is linked to abnormal leptin signaling, we hypothesized that leptin may modulate GLP-1 secretion. Leptin significantly stimulated GLP-1 secretion (by up to 250% of control) from fetal rat intestinal cells, a mouse L cell line (GLUTag), and a human L cell line (NCI-H716) in a dose-dependent manner (P < 0.05–0.001). The long form of the leptin receptor was shown to be expressed, and leptin induced the phosphorylation of STAT3 in the three cell types. The leptin receptor was also expressed by rodent and human intestinal L cells, and leptin (1 mg/kg i.p.) significantly stimulated GLP-1 secretion in rats and ob/ob mice. To determine the effect of leptin resistance on GLP-1 secretion, C57BL/6 mice were fed a high-fat (45%) or low-fat (10%) diet for 8 weeks. Mice on the high-fat diet became obese; developed glucose intolerance, hyperinsulinemia, and hyperleptinemia; and were leptin resistant. Mice on the high-fat diet also had twofold lower basal plasma GLP-1 and a diminished GLP-1 response to oral glucose, by 28.5 ± 5.0% (P < 0.05). These results show for the first time that leptin stimulates GLP-1 secretion from rodent and human intestinal L cells, and they suggest that leptin resistance may account for the decreased levels of GLP-1 found in obese humans.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
P. G. Cammisotto, D. Gingras, and M. Bendayan
Transcytosis of gastric leptin through the rat duodenal mucosa
Am J Physiol Gastrointest Liver Physiol, October 1, 2007; 293(4): G773 - G779.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
L. Simonsen, S. Pilgaard, C. Orskov, M. M. Rosenkilde, B. Hartmann, J. J. Holst, and C. F. Deacon
Exendin-4, but not dipeptidyl peptidase IV inhibition, increases small intestinal mass in GK rats
Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G288 - G295.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
Y. Anini, A. Izzo, G. Y. Oudit, P. H. Backx, and P. L. Brubaker
Role of phosphatidylinositol-3 kinase-{gamma} in the actions of glucagon-like peptide-2 on the murine small intestine
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1599 - E1606.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. Iakoubov, A. Izzo, A. Yeung, C. I. Whiteside, and P. L. Brubaker
Protein Kinase C{zeta} Is Required for Oleic Acid-Induced Secretion of Glucagon-Like Peptide-1 by Intestinal Endocrine L Cells
Endocrinology, March 1, 2007; 148(3): 1089 - 1098.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
G. E. Lim and P. L. Brubaker
Glucagon-Like Peptide 1 Secretion by the L-Cell: The View From Within
Diabetes, December 1, 2006; 55(Supplement_2): S70 - S77.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
N. Rozengurt, S. V. Wu, M. C. Chen, C. Huang, C. Sternini, and E. Rozengurt
Colocalization of the {alpha}-subunit of gustducin with PYY and GLP-1 in L cells of human colon
Am J Physiol Gastrointest Liver Physiol, November 1, 2006; 291(5): G792 - G802.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
P. L. BRUBAKER
The Glucagon-Like Peptides: Pleiotropic Regulators of Nutrient Homeostasis
Ann. N.Y. Acad. Sci., July 1, 2006; 1070(1): 10 - 26.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Park, X. Dong, T. L. Fisher, S. Dunn, A. K. Omer, G. Weir, and M. F. White
Exendin-4 Uses Irs2 Signaling to Mediate Pancreatic beta Cell Growth and Function
J. Biol. Chem., January 13, 2006; 281(2): 1159 - 1168.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. W. le Roux, R. L. Batterham, S. J. B. Aylwin, M. Patterson, C. M. Borg, K. J. Wynne, A. Kent, R. P. Vincent, J. Gardiner, M. A. Ghatei, et al.
Attenuated Peptide YY Release in Obese Subjects Is Associated with Reduced Satiety
Endocrinology, January 1, 2006; 147(1): 3 - 8.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Aparicio, S. Kermorgant, D. Darmoul, S. Guilmeau, K. Hormi, D. Mahieu-Caputo, and T. Lehy
Leptin and Ob-Rb Receptor Isoform in the Human Digestive Tract during Fetal Development
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6177 - 6184.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
V. A. Gault, N. Irwin, B. D. Green, J. T. McCluskey, B. Greer, C. J. Bailey, P. Harriott, F. P.M. O'Harte, and P. R. Flatt
Chemical Ablation of Gastric Inhibitory Polypeptide Receptor Action by Daily (Pro3)GIP Administration Improves Glucose Tolerance and Ameliorates Insulin Resistance and Abnormalities of Islet Structure in Obesity-Related Diabetes
Diabetes, August 1, 2005; 54(8): 2436 - 2446.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
B D Green, N Irwin, V A Gault, C J Bailey, F P M O'Harte, and P R Flatt
Chronic treatment with exendin(9-39)amide indicates a minor role for endogenous glucagon-like peptide-1 in metabolic abnormalities of obesity-related diabetes in ob/ob mice
J. Endocrinol., May 1, 2005; 185(2): 307 - 317.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. Ducroc, S. Guilmeau, K. Akasbi, H. Devaud, M. Buyse, and A. Bado
Luminal Leptin Induces Rapid Inhibition of Active Intestinal Absorption of Glucose Mediated by Sodium-Glucose Cotransporter 1
Diabetes, February 1, 2005; 54(2): 348 - 354.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
Y. Anini and P. L. Brubaker
Muscarinic Receptors Control Glucagon-Like Peptide 1 Secretion by Human Endocrine L Cells
Endocrinology, July 1, 2003; 144(7): 3244 - 3250.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
X. Cao, G. Flock, C. Choi, D. M. Irwin, and D. J. Drucker
Aberrant Regulation of Human Intestinal Proglucagon Gene Expression in the NCI-H716 Cell Line
Endocrinology, May 1, 2003; 144(5): 2025 - 2033.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2003 by the American Diabetes Association.